These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10480509)

  • 21. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
    Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
    Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
    Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index.
    Rolandsson O; Hägg E; Hampe C; Sullivan EP; Nilsson M; Jansson G; Hallmans G; Lernmark A
    Diabetologia; 1999 May; 42(5):555-9. PubMed ID: 10333047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.
    Davis TM; Zimmet P; Davis WA; Bruce DG; Fida S; Mackay IR
    Diabet Med; 2000 Sep; 17(9):667-74. PubMed ID: 11051287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.
    Hummel M; Durinovic-Bello I; Bonifacio E; Lampasona V; Endl J; Fessele S; Then Bergh F; Trenkwalder C; Standl E; Ziegler AG
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):204-8. PubMed ID: 9703171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
    Hawa MI; Fava D; Medici F; Deng YJ; Notkins AL; De Mattia G; Leslie RD
    Diabetes Care; 2000 Feb; 23(2):228-33. PubMed ID: 10868836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay.
    Westerlund-Karlsson A; Suonpää K; Ankelo M; Ilonen J; Knip M; Hinkkanen AE
    Clin Chem; 2003 Jun; 49(6 Pt 1):916-23. PubMed ID: 12765988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation.
    Thivolet C; Abou-Amara S; Martin X; Lefrancois N; Petruzzo P; McGregor B; Bosshard S; Dubernard JM
    Transplantation; 2000 Jan; 69(1):99-103. PubMed ID: 10653387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
    Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
    Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
    Buzzetti R; Spoletini M; Zampetti S; Campagna G; Marandola L; Panimolle F; Dotta F; Tiberti C;
    Diabetes Care; 2015 Mar; 38(3):513-20. PubMed ID: 25567348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.
    Mett V; Shamloul AM; Hirai H; Zhou Z; Notkins A; Yusibov V
    Transgenic Res; 2007 Feb; 16(1):77-84. PubMed ID: 17103024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autonomic function and autoantibodies to autonomic nervous structures, glutamic acid decarboxylase and islet tyrosine phosphatase in adolescent patients with IDDM.
    Zanone MM; Burchio S; Quadri R; Pietropaolo M; Sacchetti C; Rabbone I; Chiandussi L; Cerutti F; Peakman M
    J Neuroimmunol; 1998 Jul; 87(1-2):1-10. PubMed ID: 9670839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
    Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
    Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
    J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
    Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.